Does A Private Sale Trigger The ‘On-Sale Bar’ For Patents?
From oral arguments in this case, it’s not clear how the Supreme Court will ultimately decide.
From oral arguments in this case, it’s not clear how the Supreme Court will ultimately decide.
How will SCOTUS address the issue? That is anything but certain.
Why should a government agency not be able to correct its own mistakes?
The Federal Circuit will continue in its efforts to bring uniformity to patent law, and will not shy away from challenges presented by the America Invents Act.
Here are three big reasons why, according to IP columnist Tom Kulik.
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
Its new features transform how you can track and analyze the more than 200,000 bills, regulations, and other measures set to be introduced this year.
This Biglaw partner brings pharma experience to law firm cases.
Is the field of IP litigation still worth getting into?